Parathyroid hormone-related protein localization in breast cancers predict improved prognosis

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2250-2256

  Henderson, Michael A ^a   Danks, Janine A ^b,c   Slavin, John L ^b   Byrnes, Graham B ^a   Choong, Peter F M ^b   Spillane, John B ^a   Hopper, John L ^a   Martin, T John ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MENOPAUSE; MICROENVIRONMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; STAINING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PARATHYROID HORMONE-RELATED PROTEIN; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33644523368     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2814     Document Type: Article

References (48)

1. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61-6.
2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
3. Nicolson GL. Cancer metastases: tumour and host cell organ properties important in metastasis to specific organs. Biochim Biophys Acta 1988;948:175-224.
4. Mundy GR, Martin TJ. Pathophysiology of skeletal complications of cancer. In: Mundy GR, Martin TJ, editors. Handbook of experimental pharmacology. Physiology and pharmacology of bone. Berlin: Springer-Verlag; 1993. Vol. 107. p. 641-67.
5. Clohisy DR, Perkins SL, Ranmaraine ML. Review of cellular mechanisms of tumor osteolysis. Clin Orthop 2000;373:104-14.
6. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-93.
7. Southby J, Kissin MW, Danks JA, et al. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res 1990;50:7710-6.
8. Grill V, Ho P, Body JJ, et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991;73:1309-15.
9. Powell GJ, Southby J, Danks JA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 1991;51:3059-61.
10. Yin JJ, Selander K, Chirgwin JM, et al. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999;103:197-206.
11. Guise TA, Yin JJ, Taylor SD, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 1996;98:1544-9.
12. Thomas RJ, Guise TA, Yin JJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 1999;140:4451-8.
13. Henderson MA, Danks JA, Moseley JM, et al. Parathyroid hormone-related protein production by breast cancers associated with improved survival, and reduced bone metastases. J Natl Cancer Inst 2001;93:234-7.
14. Danks JA, Ebeling PR, Hayman J, et al. Parathyroid hormone-related protein: Immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 1989;4:273-8.
15. Danks JA, Ebeling PR, Hayman JA, et al. Immunohistochemical localization of parathyroid hormone-related protein in parathyroid adenoma and hyperplasia. J Pathol 1990;161:27-33.
16. American Joint Commission on Cancer. In: Greene FL, Page DL, Fleming I.D, Fritz A, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual. 6th ed. New York (NY): Springer: 2002. p. 171-80.
17. Elston CW. Grading of invasive carcinomas of the breast. In: Page D, Anderson T, editors. Diagnostic histopathology of the breast. Edinburgh (Scotland): Churchill-Livingstone; 1987. p. 300-11.
18. Mehta CR. The exact analysis of contingency tables in medical research. Cancer Treat Res 1995;75:177-202.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
21. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
22. Andersen PK. Testing goodness of fit of Cox's regression and life model. Biometrics 1982;38:67-77.
23. Gallwitz WE, Guise TA, Mundy GR. Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo. J Clin Invest 2002;110:1559-72.
24. Guise TA, Yin JJ, Thomas RJ, et al. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone 2002;30:670-6.
25. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.
26. Bendre MS, Gaddy-Kurten D, Mon-Foote T, et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 2002;62:5571-9.
27. Muller A, Catron N, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
28. Murray LJ, Abrams TJ, Long KR, et al. SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer metastasis model. Clin Exp Metastasis 2003;20:757-66.
29. Kissin MW, Henderson MA, Danks JA, et al. Parathyroid hormone related protein in breast cancers of widely varying prognosis. Eur J Surg Oncol 1993;19:134-42.
30. Bundred NJ, Walker RA, Ratcliffe WA, et al. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 1992;28:690-2.
31. Liapis H, Crouch EC, Grosso LE, et al. Expression of parathyroid-like protein in normal, proliferating and neoplastic breast tissue. Am J Pathol 1993;143:1169-78.
32. Bouizar Z, Spyratos F, deVernejoul MC. The parathyroid hormone-related protein (PTHrP) gene; use of downstream TATA promoter and PTHrP 1-139 coding pathways in primary breast cancers vary with occurrence of bone metastases. J Bone Miner Res 1999;14:406-14.
33. Weigelt B, Glas AM, Wessels LFA, et al. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Nat Acad Sci U S A 2003;100:15001-5.
34. Martin TJ. Manipulating the environment for cancer cells in bone; a novel therapeutic approach. J Clin Invest 2002;110:1399-401.
35. Sells Galvin RJ, Gatlin CL, Horn JW, Fuson TR. TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem Biophys Res Commun 1999;265:233-9.
36. Sanders JL, Chattopadhyay N, Kifor O, et al. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 2000;141:4357-64.
37. Martin J, Moseley JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol 1997;154:823-37.
38. Wysolmerski JJ, Stewart AF, Martin TJ. Physiological actions of parathyroid hormone (PTH) and PTH-related protein: epidermal, mammary, reproductive, and pancreatic tissues. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. Chapter 29. 2nd ed. New York: Academic Press; 2001.
39. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGFβ in homeostasis and cancer. Nat Rev Cancer 2003;3:807-18.
40. Wakefield LM, Roberts AB. TGFβ signalling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002;12:22-9.
41. Tang B, Vu M, Booker T, et al. TGFβ switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003;112:1116-24.
42. Wysolmerski JJ, Philbrick WM, Dunbar ME, et al. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 1998;125:1285-94.
43. Wysolmerski JJ, McCaughern-Carucci JF, et al. Over-expression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995;121:3539-47.
44. Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000;103:41-50.
45. Martin TJ, Gillespie MT. Receptor activator of nuclear factor kB (RANKL): another link between breast and bone. Trends Endocrinol Metab 2001;12:4-6.
46. Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene expression signature predicts survival in lymph node negative and positive breast cancer patients. N Eng J Med 2002;347:1999-2009.
47. van't Veer LJ, Dai H, Van De Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
48. Minn AJ. Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005;115:44-55.